Potential therapeutic solution for Clostridioides difficile infection: Current scenario and future prospects

Clostridioides difficile previously known as Clostridium difficile is one of the three most potent human pathogens associated with antibiotic-associated diarrhoea and damage to the colon. Although advanced healthcare facilities with the development of new antibiotics are now available, these are associated with either treatment failure or disease recurrence. Any reason that disturbs the microbiome such as antibiotic treatment, unbalanced diet, stress and chronic disease may allow C. difficile , to adhere, colonize, grow and reproduce and eventually cause disease recurrence. With increasing knowledge about the natural defence mechanism of microbiome against gut pathogens, interest in non-antibiotic alternatives like prebiotics, synbiotics, probiotics, and postbiotics is quickly evolving. The gut microenvironment can be suitably modified by using prebiotics and probiotics either alone or by using their mixture as synbiotics. The gut microbiome prevents pathogen adhesion either by physical competition or by the proliferation of anti-inflammatory and antimicrobial products. Besides, there are other possible methods such as faecal matter transplantation (FMT) and microbiome replacement therapies (MRT) for the repopulation of the gastrointestinal tract. In this article, we review current treatment strategies for C. difficile infection (CDI) using prebiotics, probiotics, synbiotics, postbiotic FMT, and MRT. The article will give useful insight into the current therapies of CDI and their future developments. • The gut microenvironment can be suitably modified by using prebiotics, probiotics, postbiotics, and synbiotics. • The gut microbiome prevents pathogen adhesion either by physical competition or by the proliferation of anti-inflammatory and antimicrobial products. • FMT and MRT are the best treatment strategies for the repopulation of the gastrointestinal tract. • More clinical trials are needed for the vast application of prebiotics, probiotics and synbiotics.

Authors

Institutions

Publication Details

Journal
Medicine in Microecology
Published
2025-02-07
DOI
https://doi.org/10.1016/j.medmic.2025.100121
Citations
5
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
6.98
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential therapeutic solution for Clostridioides difficile infection: Current scenario and future prospects

Chandrashekhar Singh, Richa Upadhyay, Anjali Singh, Deepjyoti Singh
5 citations
Medicine in Microecology
Clostridium difficile and Clostridium perfringens research
6.98
article

Potential therapeutic solution for Clostridioides difficile infection: Current scenario and future prospects

Chandrashekhar Singh, Richa Upadhyay, Anjali Singh, Deepjyoti Singh
article en
5 citations

Abstract

Clostridioides difficile previously known as Clostridium difficile is one of the three most potent human pathogens associated with antibiotic-associated diarrhoea and damage to the colon. Although advanced healthcare facilities with the development of new antibiotics are now available, these are associated with either treatment failure or disease recurrence. Any reason that disturbs the microbiome such as antibiotic treatment, unbalanced diet, stress and chronic disease may allow C. difficile , to adhere, colonize, grow and reproduce and eventually cause disease recurrence. With increasing knowledge about the natural defence mechanism of microbiome against gut pathogens, interest in non-antibiotic alternatives like prebiotics, synbiotics, probiotics, and postbiotics is quickly evolving. The gut microenvironment can be suitably modified by using prebiotics and probiotics either alone or by using their mixture as synbiotics. The gut microbiome prevents pathogen adhesion either by physical competition or by the proliferation of anti-inflammatory and antimicrobial products. Besides, there are other possible methods such as faecal matter transplantation (FMT) and microbiome replacement therapies (MRT) for the repopulation of the gastrointestinal tract. In this article, we review current treatment strategies for C. difficile infection (CDI) using prebiotics, probiotics, synbiotics, postbiotic FMT, and MRT. The article will give useful insight into the current therapies of CDI and their future developments. • The gut microenvironment can be suitably modified by using prebiotics, probiotics, postbiotics, and synbiotics. • The gut microbiome prevents pathogen adhesion either by physical competition or by the proliferation of anti-inflammatory and antimicrobial products. • FMT and MRT are the best treatment strategies for the repopulation of the gastrointestinal tract. • More clinical trials are needed for the vast application of prebiotics, probiotics and synbiotics.

Medicine in MicroecologyVol. 24
North Carolina State University (US), Shiv Nadar University (IN), Institute of Microbiology (BY), Maharishi University of Management and Technology (IN)
Zero hunger
Openalex Percentile: Top 3%
Clostridium difficile and Clostridium perfringens research
6.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.